Frequently Asked Questions:
Following the pandemic outbreak, biopharmaceutical excipients are anticipated to become more popular due to the high demand for managing SARS-COV-2 infection and developing vaccines.
North America accounted for the most heightened share in the global Biologic Excipients market.
The demand for extended-release or sustained-release formulations and the rising demand for biologic excipients are driving the growth of the market for biologic excipients.
The organic segment had a major share in the global market in 2022.
The Oral formulation segment had a major share in the global market.